Клиномир в тестовом запуске. Кто с нами с первых дней, получит отметку «С первых дней» в профиле и первым увидит новые возможности сайта.

Зарегистрироваться
Завершено Россия

NIS-RRU-XXX-2014/2

Non-interventional Multicenter Study of Spirometry Use to Diagnose COPD and to Prescribe Treatment to COPD Patients in the Outpatient Institutions of the healthcaRe System of the Russian FederaTion

Номер протоколаNIS-RRU-XXX-2014/2
ФазаФаза не указана
Участников по плану — во всех странах исследования4 232
Сроки01.11.2014 — 01.05.2015
Начало: 1 ноября 2014Окончание: 1 мая 2015
Плановый срок исследования истёк

Постоянная ссылка: https://clinomir.ru/trials/nct/NCT02248909/

Источник: ClinicalTrials.gov (U.S. National Library of Medicine). Что откуда

Простыми словами

Словарь терминов
  • Исследование завершено, новых участников не набирают.
  • Возраст участников: любой. Остальные условия — в блоке «Кто может участвовать».
  • По плану участвуют 4232 чел. во всех странах исследования.
  • Плановая дата окончания (05.2015) уже прошла.

Пересказ собран автоматически из данных реестра, без оценки пользы и рисков. Подробно о рисках и пользе рассказывает врач центра перед подписанием согласия.

Кто может участвовать

Возрастлюбой
ПолЛюбой
Здоровые добровольцынет
Полный текст критериев (на английском, как в ClinicalTrials.gov) · включение: 13 · невключение: 10

Критерии включения

  • Patients with COPD risk factors must meet all the following inclusion criteria:
  • Age ≥ 40 years.
  • Smoker or former smoker with smoking history of ≥ 10 pack years (patient is considered to be a former smoker in case of smoking cessation for ≥6 months) (the patient smokes or smoked before but then gave up smoking. The obligatory condition: smoking history is ≥10 pack years. It means that the patient smoked a pack per day for 10 years or half a pack for 20 years or 2 packs a day for 5 years).
  • Any complaints judged by the investigator to be possibly related to the respiratory diseases (chronic cough, dyspnea, cough with sputum, feeling of stiffness in the chest) or the evidence of the chronic respiratory diseases (chronic bronchitis in remission, pneumosclerosis) in the medical chart.
  • The patient is expected to have the spirometry test performed in accordance with the current medical practice before inviting him to the study.
  • Patients considered by the investigator to be able to complete themselves questionnaires used in the current study.
  • Signed Patient's Information Sheet and Informed Consent Form.
  • Patients with previously diagnosed COPD must meet all the following inclusion criteria:
  • Male and female of any age who were diagnosed with COPD before the study starts.
  • Patients whose COPD was not the direct reason for visiting the doctor or COPD patients who have COPD symptoms or signs requiring diagnostic or therapy.
  • Patients judged by the investigator as being capable to complete themselves the questionnaires used in the current study
  • Patient was scheduled to have the spirometry test performed in accordance with the existing medical practice before inviting him/her into the study
  • Signed Patient's Information Sheet and Informed Consent Form.

Критерии невключения

  • for patients with COPD risk factors:
  • Previously diagnosed chronic obstructive pulmonary disease.
  • Patients diagnosed with asthma, pulmonary tuberculosis, congenital lung abnormality, cystic fibrosis, lung cancer or cancer of the upper respiratory tract, patients who had a lung resection in the past due to pulmonary tuberculosis and other lung surgery, patients with stenosis of the upper respiratory tract, post-tracheotomy patients with the developed fibrotic stenosis of the trachea or post-intubation trachea stenosis, patients with ribs fractures of <3 weeks, pneumo- and hydrothorax of any etiology.
  • Patients who have contraindications for performing spirometry tests, patients with acute coronary syndrome or unstable circulatory dynamics. Patients who need emergency medical care at the moment of the visit.
  • Participation in any interventional clinical trial within 3 months prior the enrollment into the study and at the moment.
  • Patients with previously diagnosed COPD must meet all the following inclusion criteria:
  • Patients diagnosed with asthma, pulmonary tuberculosis, congenital lung abnormality, cystic fibrosis, lung cancer or cancer of the upper respiratory tract, patients who had a lung resection in the past due to pulmonary tuberculosis and other lung surgery, patients with stenosis of the upper respiratory tract, post-tracheotomy patients with fibrotic stenosis of the trachea or post-intubation trachea stenosis, patients with rib fractures of <3 weeks, pneumo- and hydrothorax of any etiology.
  • Active exacerbation of chronic obstructive pulmonary disease at the moment of enrollment into the study.
  • Patients who have contraindications for performing spirometry tests, patients with acute coronary syndrome or unstable hemodynamics. Patients who need emergency medical care at the time of the visit.
  • Participation in any interventional clinical trial within 3 months prior the enrollment into the study and at the moment.

Источник: ClinicalTrials.gov, NCT02248909 · запись обновлена в реестре 1 апреля 2016.

Дизайн и результаты

ДизайнНаблюдательное
Включено участников (факт, все страны)4 232
Результатыв реестре не опубликованы
Что измеряют — первичные конечные точки (3), вторичных — 6
  • The number of COPD cases first-time identified by the spirometry in relation to the total number of patients who visited the outpatient institutions of the RF during the study — Up to 5 months
  • Percentage of prescriptions for patients with COPD that correspond to the severity of the condition of the patients according to GOLD classification and GOLD recommendations for the treatment choice — Up to 5 months
  • Distribution (%) of patients with COPD who contacted the primary care doctors during the study based on bronchial obstruction severity (GOLD 1-4) and classes according to GOLD classification (2014) — Up to 5 months

Цель исследования

This study is an observational multicenter descriptive study. The study will be conducted in primary outpatient medical institutions in different cities of the RF. Primary care doctors who are primary contact for greater part of the population in RF including COPD patients will be invited as investigators. This observational descriptive study will be conducted within the routine practice of outpatient institutions. Since spirometry is not an integral part of the current all-round clinical practice, only those sites where spirometry test is routinely used in examination of patients with COPD risk factors and when monitoring condition of COPD patients will take part in the study. Thus the decision about spirometry in every study subject will be determined only by the existing treatment approaches.

Где проходит

0 центров

Центры в реестре не указаны.

Откуда эта информация

  • ClinicalTrials.gov (U.S. National Library of Medicine) · NCT02248909 Официальный реестр (США) · загружено 9 ноября 2026
    Номер протокола, название, цель, статус, сроки, число участников, спонсор

Сведения сведены и нормализованы порталом «Клиномир»: названия компаний и центров приведены к одному написанию. Нашли ошибку? Напишите нам — исправим.

Изменения не сохранены

На этой странице есть несохранённые изменения. Если уйти со страницы, они пропадут.